Clinical observation on proteinuria treatment in hypertension and type 2 diabetes with enalaprilat joint losartan / 中国基层医药
Chinese Journal of Primary Medicine and Pharmacy
;
(12): 2205-2206, 2011.
Article
in Chinese
| WPRIM
| ID: wpr-421930
ABSTRACT
ObjectiveTo observe clinical effect of proteinuria treatment in hypertension and type 2 diabetes with enalaprilat joint losartan. Methods72 cases of hypertension and type 2 diabetes with proteinuria patients were divided into two groups randomiy,losartan and enalaprilat combination for the treatment group( n =36) ,losartan alone for the observation group( n =36) ,treatment 14 weeks. Observed two groups of blood pressure and 24h after treatment urinary albumin excretion rate. ResultsTwo groups of blood pressure than before treatment were reduced significantly(P < 0.05), but after treatment between the two groups, the difference was not statistically significant (P > 0.05 ).Two groups of patients after 14 weeks treatment, average 24h urine albumin excretion rate form( 105.2 ± 27.3 ) μg/min, ( 110. 3 ± 28.0) μg/min fell to(72.6 ± 26.5 ) μg/min, ( 87.5 ± 24.9 ) μg/min ( P < 0. 01 ), the treatment group reduced more significant(P <0.05). ConclusionEnalaprilat joint losartan treatment at the same time,the effective step-down pressure, could improve the type 2 diabetes patients with early renal damage, and it suggested the early renal damage patients should be combined antihypertensive therapy as soon as possible.
Full text:
Available
Index:
WPRIM (Western Pacific)
Type of study:
Controlled clinical trial
Language:
Chinese
Journal:
Chinese Journal of Primary Medicine and Pharmacy
Year:
2011
Type:
Article
Similar
MEDLINE
...
LILACS
LIS